$8.87 +0.10 (%) Halozyme Therapeutics Inc - NASDAQ

Nov. 26, 2014 | 04:00 PM

Partner Headlines

  1. Halozyme Therapeutics Plummets On Q3 Losses

    Benzinga | Nov. 10, 2014 | 17:19PM EST
  2. Earnings Scheduled For November 10, 2014

    Benzinga | Nov. 10, 2014 | 05:36AM EST
  3. Insider Buys at Halozyme Look to Improve Stock Outlook

    GuruFocus | Sep. 18, 2014 | 17:49PM EST
  4. Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer

    Benzinga | Sep. 18, 2014 | 09:04AM EST
  5. Morning Market Movers

    Benzinga | Sep. 15, 2014 | 09:42AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 15, 2014 | 08:06AM EST
  7. How Can Mattel, Inc. And Other Toymakers Beat Lego?

    Benzinga | Sep. 8, 2014 | 13:23PM EST
  8. Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation

    Benzinga | Sep. 3, 2014 | 08:35AM EST
  9. Intercept Pharma Soars On Positive Liver Drug Data

    IBD | Aug. 11, 2014 | 22:20PM EST
  10. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga | Jul. 31, 2014 | 14:45PM EST
  11. Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 Clinical Trial

    Benzinga | Jul. 22, 2014 | 09:02AM EST
  12. Benzinga's Top Initiations

    Benzinga | Jul. 11, 2014 | 09:18AM EST
  13. JP Morgan Initiates Halozyme Therapeutics With Outperform

    Benzinga | Jul. 11, 2014 | 07:54AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 25, 2014 | 08:11AM EST
  15. Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results

    Benzinga | Jun. 5, 2014 | 14:52PM EST
  16. Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20

    Benzinga | Jun. 5, 2014 | 11:29AM EST
  17. Morning Market Movers

    Benzinga | Jun. 5, 2014 | 09:40AM EST
  18. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 5, 2014 | 08:10AM EST
  19. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down

    Benzinga | May. 13, 2014 | 15:44PM EST
  20. Mid-Day Movers: GORO, HALO, COCO, UEC, EVDY Moving Higher; RDEN, CALL, DXPE, FTEK Lower

    Benzinga | May. 13, 2014 | 15:38PM EST
  21. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip

    Benzinga | May. 13, 2014 | 12:40PM EST
  22. Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic Alternatives

    Benzinga | May. 13, 2014 | 10:28AM EST
  23. Morning Market Movers

    Benzinga | May. 13, 2014 | 09:38AM EST
  24. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 13, 2014 | 08:06AM EST
  25. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View

    Benzinga | Apr. 15, 2014 | 10:27AM EST
  26. Morning Market Movers

    Benzinga | Apr. 15, 2014 | 09:43AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 15, 2014 | 08:09AM EST
  28. Benzinga's Top Initiations

    Benzinga | Apr. 15, 2014 | 07:56AM EST
  29. Markets Falling? Get Your Defense Ready

    Benzinga | Apr. 14, 2014 | 15:47PM EST
  30. Morning Market Losers

    Benzinga | Apr. 9, 2014 | 09:48AM EST
  31. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 9, 2014 | 08:14AM EST
  32. UPDATE: Halozyme Reports Clinical Hold of PEGPH20 Pancreatic Cancer Trial Amid Voluntary Halt

    Benzinga | Apr. 9, 2014 | 08:07AM EST
  33. Biotechs Struggling To Find A Bottom

    Benzinga | Apr. 8, 2014 | 10:24AM EST
  34. Halozyme Announces Preclinical Data Presentations At The Association Of Cancer Research Annual Meeting

    Benzinga | Apr. 8, 2014 | 09:05AM EST
  35. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum Names

    Benzinga | Apr. 4, 2014 | 15:47PM EST
  36. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat Results

    Benzinga | Apr. 4, 2014 | 12:55PM EST
  37. Halozyme Shares Plummet as Concerns Halt Trial

    FoxBusiness | Apr. 4, 2014 | 10:19AM EST
  38. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga | Apr. 4, 2014 | 10:14AM EST
  39. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 4, 2014 | 08:22AM EST
  40. UPDATE: Halozyme Announces Temporary Halt of Phase 2 Trial Enrollment

    Benzinga | Apr. 4, 2014 | 08:02AM EST
  41. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss

    Benzinga | Mar. 31, 2014 | 10:35AM EST
  42. Morning Market Movers

    Benzinga | Mar. 31, 2014 | 09:40AM EST
  43. Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, as Traders Take Month-End Profits

    Benzinga | Feb. 28, 2014 | 16:00PM EST
  44. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  45. UPDATE: Halozyme Spikes Higher on Positive CNBC Comments

    Benzinga | Dec. 18, 2013 | 12:56PM EST
  46. Microsoft's First Xbox TV Series Slated For 1H 2014

    Benzinga | Dec. 16, 2013 | 15:11PM EST
  47. Hottest Game Systems For Christmas: PlayStation 4 vs. Xbox One vs. Wii U vs. PS Vita vs. Nintendo 3DS

    Benzinga | Dec. 6, 2013 | 15:57PM EST
  48. Halozyme Receives Milestone Payment of $10M from Roche Following Commercial Launch of Herceptin SC

    Benzinga | Sep. 26, 2013 | 16:26PM EST
  49. Coming Soon: Microsoft Cortana vs. Apple Siri (AAPL, MSFT)

    Benzinga | Sep. 13, 2013 | 11:16AM EST
  50. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in EU

    Benzinga | Sep. 2, 2013 | 11:25AM EST
Trading Center